The European market for transcatheter embolization devices is valued at just over €230 million with the leading segment consisting of coil embolics, which currently represents nearly half of the market. A new report from iData Research points to growth in endovascular procedures in general with aging population and growth in predisposing conditions the main drivers.
Ageing population, improved screening and new treatments will drive GI Endoscopy market in U.S.A
Market intelligence company Millennium Research Group, reckons the U.S. Transcatheter Embolisation and Occlusion device market will grow at an average annual rate of just over nine percent through 2016, driven by an aging population and a trend away from traditional surgical procedures and toward minimally invasive procedures, with particular growth in aneurysm treatment.
In its newest arthroscopy devices report, Millennium Research Group concludes that, using USA as a benchmark, many procedure areas are underpenetrated in EU. No doubt that’s true, but can we conclude that the gap between the two markets represents a growth opportunity, or is it “just how it is”?
A new market research report has been published which claims bare metal stents will account for $1.86Bn sales by 2015. And if you buy it you get a free hour with an analyst.
Millennium Research Group believes strong growth in Radioembolization Spheres, Drug-Eluting Beads and Flow-Diverting Devices will result in a 5.5% annual market growth rate through 2016.
Oh dear oh dear oh dear. We’ve been rumbled by top research group Weight Watchers® which has identified some alarming trends in British society. Well, sort of… I don’t believe a word of it… wonder what’s on TV tonight.
68% of patients surveyed don’t think the medical devices industry is good at practising ethical marketing. Should we be surprised? Interesting survey from a global patient group audience.
It may seem a bit obvious to suggest that downward price pressure and more central contracts will be offset by an ageing population and growing procedure base in the trauma market for the next few years. But at least MRG has done its homework in what looks like a valuable and detailed report.
Millennium Research Group predict modest growth in large joint market as price pressure waters down procedure growth.
Will MRG’s report into growth in the German Left Atrial Appendage Occlusion market be a best seller. Bit nichey perhaps, but an indicator of the potential for the procedure.
Another Millennium Research Group report is released, suggesting spinal nonfusion technologies will grow significantly over the next four years globally.
Adherence to the EU Sharps Directive will result in adoption of premium priced products to prevent needlestick injury, according to Millennium Research Group.
A worldwide report on the products, technologies and markets in wound closure and anti-adhesion.
Details of how differing specialties make Medical Device purchase decisions have been quantified in Millennium Research Group’s new Perception Pulse Report
Clinical concerns about Hip Resurfacing will negatively affect growth in the Hip segment, according to a new Millennium Research Group report.